Novo Nordisk to slash Wegovy, Ozempic US list prices by up to 50%
The brand of pharmaceutical firm Novo Nordisk is displayed in entrance of its workplaces in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters Nordisk on Tuesday stated it plans to slash the monthly list prices of its standard weight problems and diabetes medication within the US by up to 50% beginning in 2027,…
